Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peripheral blood lymphocytes as target cells of retroviral vector- mediated gene transfer

1 Apr 1994

Abstract excerpt

Peripheral blood lymphocytes (PBLs) are key target cells for gene therapy of a number of inherited and acquired blood disorders. We have systematically compared four retroviral vectors, designed according to different strategies, for their efficiency in transfer and expression in human PBLs of the same reporter gene. The receptor gene used in the study codes for the human low-affinity nerve growth factor receptor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Viral gastroenteritis research and epidemiology
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 8142665
DOI: 10.1182/blood.v83.7.1988.1988

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peripheral blood lymphocytes as target cells of retroviral vector- mediated gene transferPMID 8142665Read ↗

High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes.Semantic proximity Read ↗

Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer.Semantic proximity Read ↗

Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of LymphocytesSemantic proximity Read ↗

Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral VectorsSemantic proximity Read ↗

Clinical-scale Lentiviral Vector Transduction of PBL for TCR Gene Therapy and Potential for Expression in Less-differentiated CellsSemantic proximity Read ↗

Lentiviral Vector Design for Optimal T Cell Receptor Gene Expression in the Transduction of Peripheral Blood Lymphocytes and Tumor-Infiltrating LymphocytesSemantic proximity Read ↗

American society of gene therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cellsSemantic proximity Read ↗

High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectorsSemantic proximity Read ↗

Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell–activating polypeptideSemantic proximity Read ↗

Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype.Semantic proximity Read ↗

Antibody-Directed Targeting of Retroviral Vectors via Cell Surface AntigensSemantic proximity Read ↗

Specific transgene expression in human and mouse CD4+cells using lentiviral vectors with regulatory sequences from theCD4 geneSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.